TNF and colitis: SM@siRNP can scavenge 2,2-diphenyl-1-picrylhydrazide radical, inhibit NO and proinflammatory cytokine (IL-1β, IL-6, TNF-α), significantly improved the damage of colonic mucosa in DSS-induced colitis mice (Nguyen et al., 2021).